Form 4 for NVCT Nuvectis Pharma, Inc.
Accepted 2022-05-13 00:00:00 ET · period of report 2022-05-12 · accession 0001104659-22-059890 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-05-13 | 2022-05-12 | NVCT | Shemesh Shay | Chief Dev, Ops. Off | P - Purchase | $15.85 | +1,278 | 1.24M | +0.1% | +$20.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-12 | P | A | 58 | $16.61 | 1,240,893 | D | — | — | (F4) Reflects the weighted average purchase price. The range of prices for the shares purchased was $16.46 to $17.46. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price. (F2) Includes 48,399 shares of restricted stock and 60,000 restricted stock units. |
| 2 | Common | Common Stock | 2022-05-12 | P | A | 36 | $14.58 | 1,239,651 | D | — | — | (F1) Reflects the weighted average purchase price. The range of prices for the shares purchased was $14.35 to $14.60. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price. (F2) Includes 48,399 shares of restricted stock and 60,000 restricted stock units. |
| 3 | Common | Common Stock | 2022-05-12 | P | A | 1,184 | $15.85 | 1,240,835 | D | — | — | (F3) Reflects the weighted average purchase price. The range of prices for the shares purchased was $15.45 to $16.45. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price. (F2) Includes 48,399 shares of restricted stock and 60,000 restricted stock units. |